Mouse Anti-VEGF Recombinant Antibody (clone A4.6.1)
CAT#: PABW-130
Recombinant Mouse Antibody (A4. 6. 1) is capable of binding to VEGF, expressed in Chinese Hamster Ovary cells (CHO).
Published Data
Tested Data
Inhib
Figure 1 In vivo potency and efficacy of anti-VEGF antibodies in inhibiting HM-7 (human colorectal) xenografts.
A, dose-responsive inhibition of tumor growth by A4.6.1, Y0317, B20-4.1, and G6-31 (5, 0.5, and 0.1 mg/kg, twice weekly) in HM-7 bearing mouse was shown by the tumor size (mm³) as a function of time (days). Error bars represent the S.E. (n = 10).
Liang, W. C., Wu, X., Peale, F. V., Lee, C. V., Meng, Y. G., Gutierrez, J., ... & Fuh, G. (2006). Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. Journal of Biological Chemistry, 281(2), 951-961.
ICC
Figure 2 Examination of tumor sections.
B, medium magnification images (bar = 500 μm) of pancreatic HPAC (a, e, and i) and colonic HM-7 (b, f, and j) xenografts treated with control antibody (a and b), anti-human VEGF, Avastin (A4.6.1 for HM-7) (e and f), or anti-mouse/human VEGF, G6-31 (i and j). All images are centered 1 mm from the tumor/host margin. High magnification images (bar = 50 μm) of HPAC (c, g, and k) and HM-7 (d, h, and l) tumor xenografts treated with control antibody (c and d), anti-human VEGF, Avastin (g and h), or anti-mouse/human VEGF, G6-31 (k and l). Compared with HM-7, HPAC xenografts are relatively stromarich (compare c and d). Control antibody-treated HPAC tumors have extensive stromal cells infiltration (arrowheads, c), with indistinct small-caliber vessels surrounded by connective tissue cells and matrix. Treatment of these tumors with anti-human (g) or anti-mouse/human VEGF (k) results in little change in tumor-stroma proportion. In contrast, control HM-7 tumors (d) have relatively sparse stroma, and large caliber thin walled vessels (arrow). Treatment with anti-human VEGF (h) reduces vessel diameter and increases the relative amount of stromal matrix and cells around remaining vessels. Similar but more dramatic changes occur when HM-7 tumors are treated with anti-mouse/human VEGF, G6-31 (l). Images c, d, g, h, and k are centered 1 mm from the tumor/host margin (left in the images); image l is centered 200 μm from the tumor/host margin (in this sample, only necrotic tumor is present at 1 mm from the host margin).
Liang, W. C., Wu, X., Peale, F. V., Lee, C. V., Meng, Y. G., Gutierrez, J., ... & Fuh, G. (2006). Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. Journal of Biological Chemistry, 281(2), 951-961.
❮
❯
WB
Figure 1 Mouse Anti-VEGF Recombinant Antibody (PABW-130) in WB
Western blot analysis was performed with 0.1 µg (lane 1), 0.3 µg(lane 2), and 0.6 µg (lane 3) recombinant human VEGF onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with PABW-130 at 2ng/μL overnight at 4°C on a rocking platform. Then probed with Goat anti-Mouse IgG HRP secondary antibody at a dilution of 1:3,000 for one hour. Chemiluminescent was detected.
DB
Figure 2 Mouse Anti-VEGF Recombinant Antibody (PABW-130) in Dot Blot
Dot Blot analysis of PABW-130 was performed by coating with human VEGF antigen.
PABW-130 incubation concentration: 2 ng/μL.
The secondary antibody: HRP-Anti-Mouse IgG (H+L)
ELISA
Figure 3 Mouse Anti-VEGF Recombinant Antibody (PABW-130) in ELISA
ELISA analysis of PABW-130 was performed by coating with recombinant human VEGF antigen. Then blocked with BSA, and incubated with PABW-130 at a starting concentration of 2.5 µg/mL. The HRP-conjugated Goat anti-Mouse IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
❮
❯
Specifications
- Immunogen
- Human Vascular endothelial growth factor
- Host Species
- Mouse
- Type
- Mouse IgG
- Specificity
- Human VEGF
- Species Reactivity
- Human
- Clone
- A4.6.1
- Applications
- Neut, ELISA, Inhib, ICC, WB
Product Property
- Purity
- >95% as determined by SDS-PAGE and HPLC analysis
- Concentration
- Please refer to the vial label for the specific concentration.
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Applications
- Application Notes
- The VEGF antibody has been reported in applications of Neutralization, Enzyme-linked Immunosorbent Assay, Inhibition, Immunocytochemistry, Western Blot.
Target
- Alternative Names
- Vascular endothelial growth factor; VEGF
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for PABW-130. Click the button above to contact us or submit your feedback about this product.
Versatility for Various Applications
As a researcher delving into vascular biology, I've found this antibody particularly versatile for applications like ELISA and ICC. It stands out due to its high specificity and purity, ensuring that I get precise results no matter the application. Such versatility makes it a staple in my research toolkit.
Reliable for VEGF Pathway Studies
This antibody has exceeded expectations with its performance in VEGF pathways studies. The ease of use and the clear distinction it provides in protein analysis using Western Blot techniques make this product a true asset. It's further enhanced by the robust support offered by Creative Biolabs.
Q&As
-
What are the recommended research applications for the Mouse Anti-VEGF Recombinant Antibody (clone A4.6.1)?
A: This antibody is highly suited for a variety of laboratory techniques such as Neutralization, ELISA, Immunocytochemistry (ICC), and Western Blot (WB) applications. It allows researchers to examine VEGF levels and investigate its role in processes like angiogenesis, which is particularly relevant in cancer research and vascular biology studies.
-
What are the storage and handling recommendations for maintaining the stability of this antibody?
A: For optimal stability, store the antibody at +4°C for short-term (1-2 weeks) and at -20°C for long-term storage. It's important to aliquot the antibody upon first receipt to avoid repeated freeze-thaw cycles, which could adversely affect its performance.
View the frequently asked questions answered by Creative Biolabs Support.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# PABW-130, RRID: AB_3111686)
Copy citation
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Related Diseases
Bladder Cancer
Rheumatoid Arthritis
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "Clone A4.6.1"
- CAT
- Product Name
See other products for "VEGF"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1036 | Recombinant Anti-VEGF Antibody | ELISA, WB, Dot, FuncS | IgG |
| HPAB-1377LY | Mouse Anti-VEGF Recombinant Antibody (HPAB-1377LY) | ELISA, Inhib | Mouse IgG |
| HPAB-2709LY | Human Anti-VEGF Recombinant Antibody (clone YS03) | ELISA | Human IgG |
| HPAB-J0264-YC | Human Anti-VEGF Recombinant Antibody (clone G12) | ELISA | Human IgG |
| HPAB-J0265-YC | Human Anti-VEGF Recombinant Antibody (clone E9) | ELISA | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1036-F(E) | Recombinant Anti-VEGF Antibody Fab Fragment | RIA, IF, FuncS | Fab |
| HPAB-0746LY-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (HPAB-0746LY-F(E)) | ELISA | Humanized Fab |
| HPAB-1377LY-F(E) | Mouse Anti-VEGF Recombinant Antibody; Fab Fragment (HPAB-1377LY-F(E)) | ELISA, Inhib | Mouse Fab |
| HPAB-AP213-YC-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (HPAB-AP213-YC-F(E)) | ELISA | Human Fab |
| HPAB-J0264-YC-F(E) | Human Anti-VEGF Recombinant Antibody (clone G12); Fab Fragment | ELISA, Neut | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1036-S(P) | Recombinant Anti-VEGF Antibody scFv Fragment | ELISA, WB, IP, FuncS | scFv |
| HPAB-0746LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-0746LY-S(P)) | ELISA | Humanized scfv |
| HPAB-J0264-YC-S(P) | Human Anti-VEGF Recombinant Antibody (clone G12); scFv Fragment | ELISA, Neut | Human scFv |
| HPAB-J0265-YC-S(P) | Human Anti-VEGF Recombinant Antibody (clone E9); scFv Fragment | ELISA, Neut | Human scFv |
| HPAB-J0269-YC-S(P) | Mouse Anti-VEGF Recombinant Antibody (clone EGF165); scFv Fragment | ELISA, WB | Mouse scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0345CL-S(P) | Anti-Human VEGF Recombinant Antibody scFv Fragment (4D3) | ELISA, FuncS, Inhib | |
| TAB-0346CL-S(P) | Anti-Human VEGF Recombinant Antibody scFv Fragment (FD006) | ELISA, FuncS, Inhib | Human antibody |
| TAB-0345CL-F(E) | Anti-Human VEGF Recombinant Antibody Fab Fragment (4D3) | ELISA, FuncS, Inhib | |
| TAB-0346CL-F(E) | Anti-Human VEGF Recombinant Antibody Fab Fragment (FD006) | ELISA, FuncS, Inhib | Human antibody |
| TAB-286CQ | Anti-Human VEGF Recombinant Antibody (BD2) | ELISA, WB, Neut | Human antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-285CQ | Mouse Anti-VEGF Recombinant Antibody (TAB-285CQ) | ELISA, WB, Inhib | Mouse IgG1 |
| TAB-287CQ | Mouse Anti-VEGF Recombinant Antibody (TAB-287CQ) | ELISA | Mouse IgG1, κ |
| TAB-290CQ | Anti-Human VEGF Recombinant Antibody | ELISA, WB, Neut | |
| TAB-303CQ | Anti-Human VEGF Recombinant Antibody (TAB-303CQ) | ELISA, WB, Neut | |
| PABX-187-F (E) | Recombinant Mouse Anti-VEGF Antibody Fab Fragment (YADS1 ) | WB, ELISA, Neut, FuncS | Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-288CQ | Human Anti-VEGF Recombinant Antibody (TAB-288CQ) | ELISA | Chimeric (Mouse/Human) IgG1, κ |
| TAB-301CQ | Human Anti-VEGF Recombinant Antibody (TAB-301CQ) | ELISA, FC, IHC, WB | Chimeric (Mouse/Human) IgG1, κ |
| TAB-288CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-288CQ-S(P)) | ELISA, WB, IHC, Block | Human scFv |
| TAB-301CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-301CQ-S(P)) | ELISA, FC, IHC, WB | Human scFv |
| PABX-185-F (E) | Recombinant Mouse Anti-VEGF Antibody Fab Fragment (Fab-12) | ELISA, FuncS | Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-289CQ | Human Anti-VEGF Recombinant Antibody (TAB-289CQ) | ELISA | Human IgG1, κ |
| TAB-293CQ | Anti-Human VEGF Recombinant Antibody (HAB1) | WB | Humanized antibody |
| TAB-294CQ | Anti-Human VEGF Recombinant Antibody (hAB2) | ELISA, Inhib | Humanized antibody |
| TAB-295CQ | Anti-Human VEGF Recombinant Antibody (hAB3) | ELISA, Inhib | Humanized antibody |
| TAB-302CQ | Anti-Human VEGF Recombinant Antibody (TAB-302CQ) | ELISA, IHC | Humanized antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-096LC | Recombinant Anti-Human VEGF Antibody (Fc glycosylation) | ELISA | Humanized antibody |
| Gly-143LC | Recombinant Anti-Human VEGF Antibody (Fc glycosylation) | ELISA | Humanized antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-179LC | Recombinant Anti-Human VEGF Antibody (Non-glycosylated) | ELISA | Human antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOR-4485 | Rabbit Anti-VEGF Recombinant Antibody (clone SI581DS) | ELISA | Rabbit IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-J0267-YC | Recombinant Camelid Anti-VEGF Single Domain Antibody (HPAB-J0267-YC) | ELISA, Neut | Camelid VHH |
| HPAB-J0268-YC | Recombinant Camelid Anti-VEGF Single Domain Antibody (HPAB-J0268-YC) | ELISA, Neut | Camelid VHH |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: Inhib, Cyt
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
-2.png)
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, FC, WB, Block
Application: FC, ADCC, CDC, Inhib
Application: IF, IP, Neut, FuncS, ELISA, FC
Application: ELISA, IHC, WB
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
